Member Info for ThinShins

Agree with @C1p2D , begs the question why convert now

Lets hope for us all that the RNS does come this month but just keep in mind that Q2 does run up to end of June. going past Q2 is also a possibility if there are any hiccups.

@Hogbog what makes you so confident that a RNS is due imminently, is it purely the trade activity?

Hi Hogbog,

Any reason in particular you think today afternoon will be significant other than the buying? have you heard anything from your contacts.

Thanks in advance.

Its been in the dropdown for a good while.

Only thing different is as hogbog pointed out is that the pop-up is no longer active. Maybe it was only set to be active for a specific duration.

Hi HogBog,

Yes you are correct the popup doesnt appear for me either.

17 April - AACR Annual Meeting 2026

01 May - HOPE Summit 2026

13 May - Health SuperNova 2026

29 May - 2026 ASCO Annual Meeting

Regards to Cizzle Bio site the only recent change I have noticed in last few days was that Dr Ajay no longer appears as part of the team and looks as though Yanghee Woo, M.D has come in his place.

Not too relevant to us as they are more involved in the DEX-G2 side of things.

Not to put a dampner on things but its exactly same as when I first noticed the updated site and reported it here, check my post from 18/03.

Hi Chris,

Still shows as "coming soon" from what I can see?

Can somebody please share how to access the Telegram group?

Https://invest.cizzlebio.com/

Possibly outdated but it is shown as $295 , if you scroll down on the link above to the competitors section there is a table comparing acessability/cost/sensitivity

Https://www.lse.co.uk/rns/CIZ/completion-of-evaluation-programme-with-bio-techne-hzasaflq4sfrqt4.html

Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple WesternTM Platform

I suspect a lot of Ciz's resources were/are tied up atm supporting the US launch with Prof Dawn and her team being on site at Omni.

Once the rollout progresses hopefully they can then focus on other markets such as UK/EU/China

- US Launch

- Update on UK

- Update on China (IIRC somebody had communication with Tim who advised company is waiting on US launch before shifting attention to China)

- POC test

- Europe

- Other Cancers (Breast?)

A lot of news flow to be expected some sooner than later but exciting times for all involved.

I understand that Omni as a lab is already CLIA accredited. I wasnt referring to the lab becoming accredited but specifically for the CIZ1B test as highlighted below from recent RNS.

• BIO and the Company have been working on site, together with BIO's clinical testing partner, Omni Health Diagnostics Inc ("Omni") in their facility in in Richardson, Texas, USA to establish operating procedures ahead of submitting a full validation package for CLIA accreditation.

Once this accreditation is granted surely CIZ would need to RNS it, its not like they wouldn't be aware if it has been granted considering Prof Dawn and her team are involved.

Happy to be proven wrong the sooner this launches the better for everyone, patients and investors alike.

Hi Green,

My intention wasn't to make the convo go downhill, like I said "IF the rumors are true" rumors not originating from myself I should add, I didnt claim it has been granted I was mainly trying to imply that if CLIA was granted we would know as theyd have to RNS its ASAP, right? so as it stands in my view it hasn't yet been granted unless somebody has something to say otherwise.

If the rumors are true and CLIA has been granted and we haven't received a RNS would this not be a breach? As CLIA approval means the test is approved and ready for commercialisation, if this isn't price sensitive information then I'm not sure what is, considering the last RNS was just a general update.

How to access the Telegram group?

Thanks Bermondsey, yes I did notice that it appears to be a dual launch for the CIZ1B/DEX-G2 tests. I agree with tech that it makes sense from BIO’s perspective.